Skip to main content


Fig. 1 | Cancer Nanotechnology

Fig. 1

From: Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cells

Fig. 1

Viability of metastatic breast tumor cells (MDA-MB-231), non-metastatic mammary carcinoma cells (MCF-7) and human non-tumor mesenchymal cells (HNTMC). The assay was performed after 24- (a), 48- (b) and 72-h (c) exposure to 50, 100 and 200 μM rhodium citrate free (RC) or associated with maghemite nanoparticles (MRC). *p < 0.05, **p < 0.01, ***p < 0.005

Back to article page